• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail

Section Contents Menu



Resources for You

July 10, 2009 Approval Letter - Afluria

July 10, 2009

Our STN:   BL 125254/118

CSL Limited
Attention:  Paul R. Hartmann
1020 First Avenue
King of Prussia, PA  19406-0901

Dear Mr. Hartmann:

We have approved your request to supplement your biologics license application for Influenza Virus Vaccine, Afluria®, to include the 2009-2010 United States formulation.

Please submit all final printed labeling at the time of use and include implementation information on FDA form 356h.  Please provide PDF-format electronic copies of these labels. 

We will include the information contained in the above referenced supplement in your Biologics License Application file.

Sincerely yours,


Jerry P. Weir, Ph.D.
Division of Viral Products
Office of Vaccines Research and Review
Center for Biologics Evaluation and Research


Attachment: Approved Final Draft Labeling